Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

QUOTED. Moshe Shoham.

Executive Summary

Medtech Insight talked with Moshe Shoham about the innovative technologies and successful medical robotics companies, like Mazor Robotics, that were spun out of his lab at the Technion Institute. See what Shoham said about the future of robotic-assisted surgeries.

“There are some things that a robot can do better than a human and we are going to give them the jobs to do where they excel. The design of the surgery and the decisions are made by surgeons and that will remain for years. Maybe at some point when we have enough machine learning and data, maybe then the decisions will be made by robots.” – Moshe Shoham, head of medical robotics laboratory, Technion-Israel Institute of Technology

Find out more: Exec Chat: Israel’s Authority On Medical Robotics Lifts Curtain Behind Technion’s Success Stories

Click here for a free trial of Medtech Insight

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

MT145419

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel